BIB

ProShares Ultra Nasdaq Biotechnology [BIB] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

BIB Stock Summary

Top 10 Correlated ETFs

BIB

Top 10 Correlated Stocks

BIB

In the News

BIB Financial details

Company Rating
-
Market Cap
92.09M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.04
Dividend %
0.06%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
13.11%
SMA50
25.45%
SMA100
50%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
40.1-62.45
52W High
+14.82%
52W Low
+77.98%
RSI
70
Rel Volume
0.13
Avg Volume
42.32K
Volume
5.7K
Perf Week
7.52%
Perf Month
21.38%
Perf Quarter
71.62%
Perf Half Y
54.39%
-
-
-
-
Beta
1.31
-
-
Volatility
1.18%, 4.15%
Prev Close
1.94%
Price
71.19
Change
1.87%

BIB Financial Performance

BIB Dividend History

BIB Frequently Asked Questions

What is ProShares Ultra Nasdaq Biotechnology stock symbol ?

ProShares Ultra Nasdaq Biotechnology is a US stock and trading under the symbol BIB

What is ProShares Ultra Nasdaq Biotechnology stock quote today ?

ProShares Ultra Nasdaq Biotechnology stock price is $71.19 today.

Is ProShares Ultra Nasdaq Biotechnology stock public?

Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.

Something similar

Top by Market Cap
LLY
MSFT
LLY.DE
AAPL
LLY.SW
Top Correlated ETFs
IBB
IBBQ
BTEC.L
SBIO.L
BTEE.L
Top Correlated Stocks
FSPHX
FBIOX
ARGX
ARGX.BR
SHSCX
Similar Market Cap
GLA1V.HE
PREMIER.NS
MMERX
BASE.TO
0333.HK

Company Profile

Financial Services Asset Management
  • Volume Average 42.32K
  • Market Capitalization 92.09M
  • Headquarters US
  • IPO Date 2010-04-09

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.